ceftolozane / tazobactam

Known as: CEFTOLOZANE/TAZOBACTAM, Ceftolozane+Tazobactam, ceftolozane - tazobactam 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background Data on the use of ceftolozane-tazobactam and emergence of ceftolozane-tazobactam resistance during multidrug… (More)
Is this relevant?
Review
2016
Review
2016
Ceftolozane/tazobactam and ceftazidime/avibactam are 2 novel β-lactam/β-lactamase combination antibiotics. The antimicrobial… (More)
  • table 1
  • table 2
  • table 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Highly Cited
2015
BACKGROUND Increasing antimicrobial resistance among pathogens causing complicated intra-abdominal infections (cIAIs) supports… (More)
Is this relevant?
Review
2015
Review
2015
Ceftolozane/tazobactam is a novel antipseudomonal β-lactam/β-lactamase inhibitor combination that is currently approved by the… (More)
Is this relevant?
Review
2014
Review
2014
The prevalence of carbapenem-resistant gram-negative bacterial pathogens (CRGNs) has increased dramatically during the last 10… (More)
  • table 1
  • table 2
Is this relevant?
2014
2014
We compared the dynamics and mechanisms of resistance development to ceftazidime, meropenem, ciprofloxacin, and ceftolozane… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
  • figure 2
Is this relevant?
Review
2014
Review
2014
Outpatient parenteral antimicrobial therapy (OPAT) has become, for many countries, an established form of healthcare delivery. At… (More)
  • table 1
  • table 2
Is this relevant?
2013
2013
Ceftolozane/tazobactam, a novel antimicrobial agent with activity against Pseudomonas aeruginosa (including drug-resistant… (More)
  • table 2
  • table 4
Is this relevant?
2012
2012
The pharmacokinetics and safety of ceftolozane, a novel cephalosporin, and tazobactam, a β-lactamase inhibitor, alone and in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?